Biohaven (BHVN) Accumulated Expenses (2021 - 2026)

Biohaven has reported Accumulated Expenses for 6 years, with the latest figure at $41.7 million in Q1 2026.

• Quarterly Accumulated Expenses fell 26.37% year-over-year to $41.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.7 million (down 26.37% YoY) and the FY2025 annual result came in at $104.3 million, up 102.56% from the prior year.
• Accumulated Expenses slipped to $41.7 million in Q1 2026 per BHVN's latest filing, from $104.3 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $104.3 million in Q4 2025 and troughed at $23.7 million in Q3 2022.
• A 5-year average of $54.1 million and a median of $51.5 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2026: Accumulated Expenses soared 122.05% in 2023, then retreated 26.37% in 2026.
• Over 5 years, Accumulated Expenses stood at $44.1 million in 2022, then declined by 9.66% to $39.8 million in 2023, then grew by 29.21% to $51.5 million in 2024, then surged by 102.56% to $104.3 million in 2025, then plunged by 60.06% to $41.7 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $41.7 million, $104.3 million, and $73.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.